Bioavailability and Bioequivalence: Pharmaceutical R&D Summit May 20-22, 2013 Doubletree by Hilton, Beijing, China

Bioavailability and Bioequivalence: Pharmaceutical R&D Summit May 20-22, 2013 Doubletree by Hilton, Beijing, China

Zahid Iqbal et al., J Bioequiv Availab 2013, 5:3 http://dx.doi.org/10.4172/0975-0851.S1.015 4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit May 20-22, 2013 DoubleTree by Hilton, Beijing, China Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Nili/Ravi Buffalos Zahid Iqbal1, Aamir Ali Khan2, Tasneem Zarfishan3, Mohiuddin Mudassar4 and Ijaz Javed5 1Department of Pharmacology, Isra University, Islamabad Campus, Pakistan 2Department of Pathology, Nishtar Medical College, Pakistan 3Department of Anatomy, Nishtar Medical College, Pakistan 4Department of Pathology, Isra University, Pakistan 5Department of Physiology and Pharmacology, University of Agriculture, Pakistan he present study was undertaken with the objective to determine the pharmacokinetics and optimal dosage regimen of Tciprofloxacin in Nili/Ravi buffalos. For this purpose, the drug was administered intramuscularly at 5 mg/kg body weight in each of eight animals. Following ciprofloxacin administration, blood samples were collected at different time intervals and analyzed for ciprofloxacin using HPLC. Pharmacokinetic parameters were calculated using two compartment open model. Peak plasma concentration (Cmax) of ciprofloxacin, 4.89 ± 0.28 µg/mL was achieved at 0.87 ± 0.03 hours (Tmax). Values for half life of absorption (t1/2 abs), distribution (t1/2 α) and elimination (t1/2 β) were 0.45 ± 0.03, 0.45 ± 0.03 and 3.05 ± 0.20 hours, respectively. The value for apparent volume of distribution (Vd) was 1.09 ± 0.06 L/kg, area under the curve (AUC) was 20.28 ± 1.13 µg.hr/ mL and total body clearance (CL) was 0.25 ± 0.02 L/hr/kg. Based on these parameters, an optimal intramuscular dosage of ciprofloxacin in adult Nili/Ravi buffalos was calculated as 17.86 mg/kg, to be repeated after 24 hours interval. These results show that ciprofloxacin in these buffalos has the general pharmacokinetic characteristics of a typical fluoroquinolone antimicrobial agent. That is, it has distribution, clearance and half life that are similar to other studies. Based on these results, it was concluded that calculated dose was higher than the dose recommended by the manufacturer and to avoid drug residues in the meat and antimicrobial resistance, this locally investigated dosage regimen should be strictly followed in local buffalos. Biography Zahid Iqbal has completed his Ph.D. in 2008 at the age of 28 years from University of Agriculture, Faisalabad, Pakistan. He is working as an Associate Professor in the Department of Pharmacology, Al-Nafees Medical College, Isra University, Islamabad Campus, Islamabad, Pakistan. He has published more than 15 papers in reputed journals and serving as technical editor of Isra Medical Journal. [email protected] J Bioequiv Availab 2013 BABE-2013 Volume 5 Issue 3 May 20-22, 2013 ISSN: 0975-0851 JBB, an open access journal Page 117 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us